SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has received U.S. Food ...
Resmed Inc (RMD) announced an update on their ongoing clinical study. ResMed’s new study, “Trial of a New Software Tool for Personalized Minimum and Maximum Pressure Recommendations in New CPAP Users ...
Sleep apnea has become a global health concern, affecting millions of people and leading to fatigue, cardiovascular disease, and other chronic health issues. To address this widespread problem, ResMed ...
A diagnosis for sleep apnea, a condition that causes breathing to temporarily stop and restart while a person is sleeping, ...
Connected sleep devicemaker ResMed today released the AirSense 11, its latest CPAP machine iteration, which includes a host of new features to treat obstructive sleep apnea. The new machine has many ...
How to choose, buy, and use your sleep apnea treatment A Massively Under-Diagnosed Public Health Issue Obstructive sleep apnea (OSA) is one of the most widespread chronic conditions in Canada – and ...
Technology uses real-world sleep data and machine learning to help people with sleep apnea start and stay on therapy SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the ...
SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results